Literature DB >> 19230353

Effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucoma.

Vicente Polo1, José M Larrosa, Antonio Ferreras, Enrique Borque, Luis E Pablo, Francisco M Honrubia.   

Abstract

We evaluated the efficacy of fixed combination of 0.005% latanoprost and 0.5% timolol maleate administered once daily in the evening for treating glaucoma patients. This combination proved an effective alternative to achieve an additional intraocular pressure IOP lowering effect in patients treated with either drug alone and as an alterative in patients treated with unfixed combination of latanoprost and timolol and optimal IOP control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230353

Source DB:  PubMed          Journal:  Ann Ophthalmol (Skokie)        ISSN: 1530-4086


  6 in total

1.  Effectiveness and safety of switching from prostaglandin analog monotherapy to prostaglandin/timolol fixed combination therapy or adding ripasudil.

Authors:  Kenji Inoue; Kyoko Ishida; Goji Tomita
Journal:  Jpn J Ophthalmol       Date:  2018-05-24       Impact factor: 2.447

2.  Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy.

Authors:  Kenji Inoue; Takayuki Fujimoto; Risako Higa; Ryo Moriyama; Hiromi Kohmoto; Haruka Nagumo; Masato Wakakura; Goji Tomita
Journal:  Clin Ophthalmol       Date:  2012-05-21

3.  Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination.

Authors:  Kenji Inoue; Ryoko Okayama; Risako Higa; Masato Wakakura; Goji Tomita
Journal:  Clin Ophthalmol       Date:  2012-04-18

4.  Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months.

Authors:  Kenji Inoue; Ryoko Okayama; Risako Higa; Goji Tomita
Journal:  Clin Ophthalmol       Date:  2014-07-03

5.  Comparison of latanoprost/timolol with carbonic anhydrase inhibitor and dorzolamide/timolol with prostaglandin analog in the treatment of glaucoma.

Authors:  Kenji Inoue; Shoichi Soeda; Goji Tomita
Journal:  J Ophthalmol       Date:  2014-03-05       Impact factor: 1.909

6.  Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy.

Authors:  Kenji Inoue; Mieko Masumoto; Kyoko Ishida; Goji Tomita
Journal:  Open Ophthalmol J       Date:  2017-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.